PropertyValue
?:abstract
  • In response to the outbreak of the Covid-19 pandemic, some pharmaceutical companies have patented their drugs to combat it, including those based on stem cells Questions about how to access such drugs will likely be raised because patent protection grants an exclusive right to the patent owner, to prevent someone else from benefiting from a large-scale price increase The document will then review the regulation and practice of government use in Indonesia and the possibility of such a mechanism to access Covid-19 drugs © 2020, Universidad del Zulia All rights reserved
is ?:annotates of
?:creator
?:journal
  • Utopia_y_Praxis_Latinoamericana
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Government-use license and stem cell-based pharmaceuticals patent: Equitable access to COVID-19 medications
?:type
?:who_covidence_id
  • #830271
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xdtkrum3>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xdtkrum3>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all